The UK Blood Grouping Reagents Market witnessed fluctuations from 2013, starting with a value of $83.262 million and seeing significant growth phases in 2014 and 2019. By 2023, the market reached $110.71 million, reflecting a year-on-year increase of 1.38% and a 5-year CAGR of 3.83%. Future estimates project a steady annual growth rate, with the market anticipated to reach $118.59 million by 2028, indicating a forecast 5-year CAGR of 1.08%.
Future trends to watch include advances in diagnostic technologies, increased demand for blood grouping reagents due to rising healthcare activity, and potential regulatory changes affecting market dynamics. There could be notable shifts driven by innovations and increasing healthcare investments.
